|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chari ST, Kelly K, Hollingsworth MA,
Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto
M, Cleeter DF, et al: Early detection of sporadic pancreatic
cancer: Summative review. Pancreas. 44:693–712. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bissolati M, Sandri MT, Burtulo G, Zorzino
L, Balzano G and Braga M: Portal vein-circulating tumor cells
predict liver metastases in patients with resectable pancreatic
cancer. Tumour Biol. 36:991–996. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bidard FC, Huguet F, Louvet C, Mineur L,
Bouché O, Chibaudel B, Artru P, Desseigne F, Bachet JB, Mathiot C,
et al: Circulating tumor cells in locally advanced pancreatic
adenocarcinoma: The ancillary CirCe 07 study to the LAP 07 trial.
Ann Oncol. 24:2057–2061. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin HK, Zheng S, Williams AJ, Balic M,
Groshen S, Scher HI, Fleisher M, Stadler W, Datar RH, Tai YC and
Cote RJ: Portable filter-based microdevice for detection and
characterization of circulating tumor cells. Clin Cancer Res.
16:5011–5018. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harouaka RA, Zhou MD, Yeh YT, Khan WJ, Das
A, Liu X, Christ CC, Dicker DT, Baney TS, Kaifi JT, et al: Flexible
micro spring array device for high-throughput enrichment of viable
circulating tumor cells. Clin Chem. 60:323–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lecharpentier A, Vielh P, Perez-Moreno P,
Planchard D, Soria JC and Farace F: Detection of circulating tumour
cells with a hybrid (epithelial/mesenchymal) phenotype in patients
with metastatic non-small cell lung cancer. Br J Cancer.
105:1338–1341. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Armstrong AJ, Marengo MS, Oltean S, Kemeny
G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ and
Garcia-Blanco MA: Circulating tumor cells from patients with
advanced prostate and breast cancer display both epithelial and
mesenchymal markers. Mol Cancer Res. 9:997–1007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin PP: Integrated EpCAM-independent
subtraction enrichment and iFISH strategies to detect and classify
disseminated and circulating tumors cells. Clin Transl Med.
4:382015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z,
Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating
tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Zhu Y, Zhang Z, Zhang C, Huang X
and Yuan Z: Clinical significance of pancreatic circulating tumor
cells using combined negative enrichment and
immunostaining-fluorescence in situ hybridization. J Exp Clin
Cancer Res. 35:662016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kulemann B, Pitman MB, Liss AS, Valsangkar
N, Fernández-Del Castillo C, Lillemoe KD, Hoeppner J, Mino-Kenudson
M, Warshaw AL and Thayer SP: Circulating tumor cells found in
patients with localized and advanced pancreatic cancer. Pancreas.
44:547–550. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Poruk KE, Valero V III, Saunders T,
Blackford AL, Griffin JF, Poling J, Hruban RH, Anders RA, Herman J,
Zheng L, et al: Circulating tumor cell phenotype predicts
recurrence and survival in pancreatic adenocarcinoma. Ann Surg.
264:1073–1081. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tjensvoll K, Nordgård O and Smaaland R:
Circulating tumor cells in pancreatic cancer patients: Methods of
detection and clinical implications. Int J Cancer. 134:1–8. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nagrath S, Sequist LV, Maheswaran S, Bell
DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky
A, et al: Isolation of rare circulating tumour cells in cancer
patients by microchip technology. Nature. 450:1235–1239. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sergeant G, Roskams T, van Pelt J,
Houtmeyers F, Aerts R and Topal B: Perioperative cancer cell
dissemination detected with a real-time RT-PCR assay for EpCAM is
not associated with worse prognosis in pancreatic ductal
adenocarcinoma. BMC Cancer. 11:472011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sandri MT, Zorzino L, Cassatella MC, Bassi
F, Luini A, Casadio C, Botteri E, Rotmensz N, Adamoli L and Nolè F:
Changes in circulating tumor cell detection in patients with
localized breast cancer before and after surgery. Ann Surg Oncol.
17:1539–1545. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kulemann B, Liss AS, Warshaw AL, Seifert
S, Bronsert P, Glatz T, Pitman MB and Hoeppner J: KRAS mutations in
pancreatic circulating tumor cells: A pilot study. Tumour Biol.
37:7547–7554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chang MC, Chang YT, Chen JY, Jeng YM, Yang
CY, Tien YW, Yang SH, Chen HL, Liang TY, Wang CF, et al: Clinical
significance of circulating tumor microemboli as a prognostic
marker in patients with pancreatic ductal adenocarcinoma. Clin
Chem. 62:505–513. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou JM, Krebs MG, Lancashire L, Sloane R,
Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, et
al: Clinical significance and molecular characteristics of
circulating tumor cells and circulating tumor microemboli in
patients with small-cell lung cancer. J Clin Oncol. 30:525–532.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aceto N, Bardia A, Miyamoto DT, Donaldson
MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, et al:
Circulating tumor cell clusters are oligoclonal precursors of
breast cancer metastasis. Cell. 158:1110–1122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liotta LA, Saidel MG and Kleinerman J: The
significance of hematogenous tumor cell clumps in the metastatic
process. Cancer Res. 36:889–894. 1976.PubMed/NCBI
|
|
26
|
Friedl P and Gilmour D: Collective cell
migration in morphogenesis, regeneration and cancer. Nat Rev Mol
Cell Biol. 10:445–457. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Conroy T, Desseigne F, Ychou M, Bouché O,
Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de
la Fouchardière C, et al: FOLFIRINOX versus gemcitabine for
metastatic pancreatic cancer. N Engl J Med. 364:1817–1825. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Von Hoff DD, Ervin T, Arena FP, Chiorean
EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, et
al: Increased survival in pancreatic cancer with nab-paclitaxel
plus gemcitabine. N Engl J Med. 369:1691–1703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hong Y, Li Z and Zhang Q: A circulating
tumor cell cluster-based model for tumor metastasis (Hypothesis).
Oncology Lett. 12:4891–4895. 2016. View Article : Google Scholar
|
